Edesa Biotech's total assets for Q4 2025 were $13.66M, a decrease of -7.72% from the previous quarter. EDSA total liabilities were $1.21M for the fiscal quarter, a 79.81% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.